Efgartigimod for Consolidation Therapy in gMG

Not yet recruitingOBSERVATIONAL
Enrollment

130

Participants

Timeline

Start Date

July 30, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

September 30, 2026

Conditions
Myasthenia Gravis
All Listed Sponsors
lead

Da, Yuwei, M.D.

INDIV